Literature DB >> 24952062

Evaluation of lesion and thermodynamic characteristics of Symplicity and EnligHTN renal denervation systems in a phantom renal artery model.

Sara I Al Raisi1, Jim Pouliopoulos, Michael T Barry, John Swinnen, Aravinda Thiagalingam, Stuart P Thomas, Gopal Sivagangabalan, Clara Chow, James Chong, Eddy Kizana, Pramesh Kovoor.   

Abstract

AIMS: Radiofrequency renal artery denervation has been used effectively to treat resistant hypertension. However, comparison of lesion and thermodynamic characteristics for different systems has not been previously described. We aimed to assess spatiotemporal lesion growth and ablation characteristics of Symplicity and EnligHTN systems. METHODS AND
RESULTS: A total of 39 ablations were performed in a phantom renal artery model using Symplicity (n=17) and EnligHTN (n=22) systems. The phantom model consisted of a hollowed gel block surrounding a thermochromic liquid crystal (TLC) film, exhibiting temperature sensitivity of 50-78°C. Flow was simulated using 37°C normal saline with impedance equal to blood. Radiofrequency ablations with each system were delivered with direct electrode tip contact to the TLC. Lesion size was interpreted from the TLC as the maximum dimensions of the 51°C isotherm. Mean lesion depth was 3.82 mm±0.04 versus 3.44 mm±0.03 (p<0.001) for Symplicity and EnligHTN, respectively. Mean width was 7.17 mm±0.08 versus 6.23 mm±0.07 (p<0.001), respectively. With EnligHTN, steady state temperature was achieved 20 sec earlier, and was 15°C higher than Symplicity.
CONCLUSIONS: In this phantom model, Symplicity formed larger lesions compared to EnligHTN with lower catheter-tip temperature. The clinical significance of our findings needs to be explored further.

Entities:  

Mesh:

Year:  2014        PMID: 24952062     DOI: 10.4244/EIJV10I2A46

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

1.  Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.

Authors:  Franco Rabbia; Elisa Testa; Chiara Fulcheri; Elena Berra; Silvia Di Monaco; Michele Covella; Marco Pappaccogli; Silvia Monticone; Renato Rosiello; Denis Rossato; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-03

Review 2.  Renal Denervation: Is It Ready for Prime Time?

Authors:  Lucas Lauder; Milan A Wolf; Sean S Scholz; Mathias Hohl; Felix Mahfoud; Michael Böhm
Journal:  Curr Cardiol Rep       Date:  2019-07-05       Impact factor: 2.931

3.  Reconsidering Renal Sympathetic Denervation for Heart Failure.

Authors:  W H Wilson Tang; Mark E Dunlap
Journal:  JACC Basic Transl Sci       Date:  2017-06-26

4.  Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.

Authors:  Sara I Al Raisi; Jim Pouliopoulos; Pierre Qian; Patricia King; Karen Byth; Michael T Barry; John Swinnen; Aravinda Thiagalingam; Pramesh Kovoor
Journal:  Catheter Cardiovasc Interv       Date:  2018-12-14       Impact factor: 2.692

Review 5.  Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure.

Authors:  Philipp Lurz; Karl Fengler
Journal:  Interv Cardiol       Date:  2019-05-21

6.  Validation of a Novel Renal Denervation System With Cryoablation: A Preclinical Study and Case Series.

Authors:  Meng Ji; Han Chen; Li Shen; Yi Zhang; Zhifeng Yao; Yizhe Wu; Yawei Xu; Junbo Ge
Journal:  JACC Basic Transl Sci       Date:  2022-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.